First Time Loading...

Curis Inc
NASDAQ:CRIS

Watchlist Manager
Curis Inc Logo
Curis Inc
NASDAQ:CRIS
Watchlist
Price: 16.36 USD 2.31%
Updated: May 2, 2024

Curis Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Curis Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Curis Inc
NASDAQ:CRIS
Revenue
$10m
CAGR 3-Years
-3%
CAGR 5-Years
-1%
CAGR 10-Years
-4%
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.5B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

Curis Inc
Revenue Breakdown

Breakdown by Geography
Curis Inc

Not Available

Breakdown by Segments
Curis Inc

Total Revenue: 10m USD
100%
Gross Royalty Revenue: 9.9m USD
98.8%

See Also

What is Curis Inc's Revenue?
Revenue
10m USD

Based on the financial report for Dec 31, 2023, Curis Inc's Revenue amounts to 10m USD.

What is Curis Inc's Revenue growth rate?
Revenue CAGR 10Y
-4%

Over the last year, the Revenue growth was -1%. The average annual Revenue growth rates for Curis Inc have been -3% over the past three years , -1% over the past five years , and -4% over the past ten years .